Salivary Osmometry: A Novel Paradigm in Point-of-Care Hydration Assessment

唾液渗透压测定:护理点水合评估的新范例

基本信息

  • 批准号:
    7272658
  • 负责人:
  • 金额:
    $ 10万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-05-01 至 2008-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Dehydration poses a significant and costly problem in medical care. As an example, literature estimates that 30-50% of all skilled nursing facility residents are chronically dehydrated, with resulting cost to the medical system exceeding $1 billion dollars annually. In the pediatric realm, it is estimated that over 2,000,000 deaths occur worldwide every year due to dehydration-associated causes. Currently, no effective means exist to provide accurate, inexpensive, non-invasive point-of-care evaluation of persons at risk for dehydration. In recent years, several researchers have identified salivary osmolality (the concentration of particles in saliva) as a powerful marker of human hydration. Cantimer, Inc. has been developing a microelectromechanical sensor technology that allows rapid, relatively inexpensive, non-invasive point-of-care evaluation of this property. By monitoring a readily accessible body fluid, Cantimer proposes to provide a simple tool to the healthcare provider and health consumer community for ongoing bedside assessment of hydration status in the hospital, doctor's office, long-term care/assisted living facility, or the home setting. The company has constructed a number of device prototypes, which accurately and reliably measure salivary osmolality in the laboratory setting. The goal of this Phase 1 research project would be to develop a stand-alone unit capable of repeated point-of-care measurement, and ready for entry into clinical trials. The project work would address sensor contamination and fouling; microfluidic design, initial product concept development, and other aspects of device engineering. Subsequent Phase 2 work and commercialization plan would include the formulation and initiation of appropriate clinical studies leading to the introduction of a Human Hydration Monitor into the healthcare marketplace.
描述(由申请人提供):脱水在医疗保健中是一个严重且昂贵的问题。例如,文献估计,所有熟练护理机构的居民中有30%-50%患有慢性脱水,导致医疗系统每年的成本超过10亿美元。在儿科领域,据估计,全世界每年有200多万人死于脱水相关原因。目前,没有有效的手段来为有脱水风险的人提供准确、廉价、非侵入性的护理地点评估。近年来,几位研究人员已经确认唾液渗透压(唾液中颗粒的浓度)是人类水合作用的一个强有力的标志。坎蒂默公司一直在开发一种微型机电传感器技术,可以对这一特性进行快速、相对便宜、非侵入性的护理点评估。通过监测易于获取的体液,Cantimer建议为医疗保健提供者和健康消费者社区提供一种简单的工具,用于在医院、医生办公室、长期护理/辅助生活设施或家庭环境中进行持续的床边水分状况评估。该公司已经建造了许多设备原型,可以在实验室环境中准确可靠地测量唾液渗透压。这一第一阶段研究项目的目标将是开发一个能够重复测量护理点并准备进入临床试验的独立单元。该项目的工作将涉及传感器污染和污垢;微流控设计、初始产品概念开发以及设备工程的其他方面。随后的第二阶段工作和商业化计划将包括制定和启动适当的临床研究,从而将人类水合监测引入医疗保健市场。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ray F. Stewart其他文献

Ray F. Stewart的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 10万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 10万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了